טוען...
Generation of Recombinant SARS‐CoV‐2 Using a Bacterial Artificial Chromosome
SARS‐CoV‐2, the causative agent of COVID‐19, has been responsible for a million deaths worldwide as of September 2020. At the time of this writing, there are no available US FDA−approved therapeutics for the treatment of SARS‐CoV‐2 infection. Here, we describe a detailed protocol to generate recombi...
שמור ב:
| הוצא לאור ב: | Curr Protoc Microbiol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7646048/ https://ncbi.nlm.nih.gov/pubmed/33048448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpmc.126 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|